Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2025 | Story Lilitha Dingwayo | Photo Lunga Luthuli
Bibi Essop
Bibi Essop, newly elected Universal Access Officer of the Bloemfontein Campus CSRC, celebrates her election as a representative of CUADS and students living with disabilities at the UFS.

The University of the Free State (UFS) community proudly celebrates the appointment of Bibi Essop as the newly elected Campus Student Representative Council Universal Access Officer on the Bloemfontein Campus – a role of immense importance for inclusivity, representation, and student advocacy.

Living with brittle bone syndrome, Essop brings both personal insight and leadership to her portfolio, representing the Centre for Universal Access and Disability Support (CUADS). Her election is not only a personal milestone but also a testament to the university’s growing recognition of the importance of visible leadership by students with disabilities.

By stepping into this position, Essop embodies the empowerment of students who navigate both academic life and unique personal challenges. “This is the pinnacle of my achievements this year, as I have been working towards this for the past three to four years,” she says.

She emphasises that her first priority was to understand the needs of the community she represents. “I had to make sure I know the people I represent, which gave me the opportunity to learn about the other four cohorts on our campus: students with visual impairment, hearing impairment, and learning difficulties, since I am a part of the mobility impairment cohort,” she explains.

The role of Universal Access Officer is vital in ensuring that the needs of students with disabilities remain central to discussions about inclusivity, campus infrastructure, and academic support. Essop is determined to challenge misconceptions about the position. 

“Many people assume my portfolio is restricted to CUADS students only, whereas it is so diverse that it needs to be incorporated in every other portfolio. Accessibility at every event is essential for students living with disabilities,” she says. “Many students do not attend events because they presume that they will not be accommodated.” 

Looking beyond academics, Essop hopes to work closely with fellow CSRC members to ensure inclusivity across all aspects of student life. One initiative she is particularly excited about is Casual Day on 5 September 2025 - a celebration of different disabilities aimed at fostering awareness, education, and integration among all students. 

“The CSRC has reach and influence across all three campuses. By partnering with them, CUADS can amplify its work, ensure consistent messaging, and create opportunities for engagement that are student-driven. This collaboration allows us to step outside of formal support channels and become part of broader campus conversations, events, and initiatives,” says Mosa Moerane who is the liaison, advocacy and awareness officer for CUADS. 

Moerane explains that there are differences in challenges faced by students with disabilities on three campuses. “Bloemfontein, being the largest campus, often presents challenges around scale- serving a higher number of students with diverse needs. South Campus has its own dynamics, with many first-year students who may still be navigating disclosure and adjustment. Qwaqwa students face unique geographical and infrastructural challenges. CUADS responds by tailoring support through assistive technology, academic accommodations, or advocacy for improved accessibility while keeping the student’s lived experience at the centre,” said Moerane.

“The aim is always to make students in Qwaqwa and South Campuses feel as included as those in Bloemfontein. Also having offices at South Campus and Qwaqwa Campus with CUADS Coordinators assists in ensuring that our students are supported similarly to those on Bloemfontein Campus,” she added.

As UFS continues its journey towards greater inclusivity, Essop’s appointment serves as a reminder of the importance of representation across all student cohorts. It affirms that every voice, regardless of background or circumstance, deserves to be heard.

The university congratulates Bibi Essop on this well-deserved achievement. Her leadership represents a step towards ensuring that universal access is not just a policy, but a lived reality for all UFS students. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept